Author:
Schrezenmeier Hubert,Körper Sixten,Höchsmann Britta,Weinstock Christof
Abstract
AbstractTransfusions are an essential part of supportive care in the context of HCT. RBC and platelet concentrates (PCs) are the main blood products transfused in the peri-transplant period. Here we summarize indication for transfusion, selection of product type and immunohematological challenges in the context of allogeneic stem cell transplantation.
Publisher
Springer International Publishing
Reference30 articles.
1. Armand P, Kim HT, Virtanen JM, et al. Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis. Biol Blood Marrow Transplant. 2014;20:1248–51.
2. Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016;316:2025–35.
3. Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC. Transfusion thresholds for guiding red blood cell transfusion. CochraneDatabaseSystRev. 2021;12:CD002042.
4. Chantepie SP, Mear JB, Briant AR, Vilque JP, Gac AC, Cheze S, Girault S, Turlure P, Marolleau JP, Lebon D, Charbonnier A, Jardin F, Lenain P, Peyro-Saint-Paul L, Abonnet V, Dutheil JJ, Chene Y, Bazin A, Reman O, Parienti JJ. Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: a multicenter randomized controlled clinical trial. Leuk Res. 2023;129:107058.
5. Christou G, Iyengar A, Shorr R, et al. Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials. Transfusion. 2016;56:2607–14.